Skip to main content
Avenue Therapeutics
  • Home Redirect
  • About
    • Management Team
    • Board of Directors
  • Publications
    • Publications
  • Investors
    • Investors Home
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote & Chart
    • Financial Information
      • Financial Reports
      • SEC Filings
      • Interactive Financials
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Management Team
      • Board of Directors
    • Investor Resources
      • FAQs
      • Email Alerts & RSS Feeds
      • Contact Us
  • Contact Us
  • Home Redirect
  • About
    • Management Team
    • Board of Directors
  • Publications
    • Publications
  • Investors
    • Investors Home
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote & Chart
    • Financial Information
      • Financial Reports
      • SEC Filings
      • Interactive Financials
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Management Team
      • Board of Directors
    • Investor Resources
      • FAQs
      • Email Alerts & RSS Feeds
      • Contact Us
  • Contact Us

Press Releases

Normal
Press Release RSS Feed (opens in new window)
Press release year list 2021 2020 2019 2018 2017 2015
December 18, 2020
Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis
December 18, 2020
Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network
December 17, 2020
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
October 12, 2020
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
September 9, 2020
Avenue Therapeutics Announces Publication of a Review of IV Tramadol
August 14, 2020
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
July 21, 2020
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
June 5, 2020
Avenue Therapeutics Announces Publications in Peer-Reviewed Journals
May 29, 2020
Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders
May 11, 2020
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
April 23, 2020
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
March 30, 2020
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
February 13, 2020
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA

Social

Investor Contact

Lucy Lu, M.D., CEO
ir@avenuetx.com

Email Alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

* Required

*
*
 
Enter the code shown above.
*

Email Alert Sign Up Confirmation

  • Privacy
  • Disclaimer
  • Contact Us
Copyright © Avenue Therapeutics
Powered By Q4 Inc. 5.52.0.6 (opens in new window)